Navigating Non-interventional Post-authorization Studies in East Asia: Regulatory Challenges, Opportunities, and Future Directions.
Saved in:
| Title: | Navigating Non-interventional Post-authorization Studies in East Asia: Regulatory Challenges, Opportunities, and Future Directions. |
|---|---|
| Authors: | Peters J; Gilead Sciences Inc., Foster City, CA, USA. jami.peters5@gilead.com., Ali AK; BeOne Medicines Ltd., San Carlos, CA, USA., Moitinho de Almeida M; GSK, Wavre, Belgium., Asao K; Kappa Medical K.K., Tokyo, Japan., Hammad TA; Takeda Development Center Americas, Inc., Cambridge, MA, USA., He X; IQVIA, Shanghai, China., Michel A; Bayer Consumer Care AG, Basel, Switzerland., Rubino A; Gilead Sciences Europe Ltd, Uxbridge, UK., Sawada S; Nippon Boehringer Ingelheim Co., Ltd., Tokyo, Japan., Sobel RE; Regeneron Pharmaceuticals, Tarrytown, NY, USA., de Vogel S; Astellas Pharma Europe B.V., Leiden, The Netherlands. |
| Source: | Drug safety [Drug Saf] 2026 Mar; Vol. 49 (3), pp. 263-271. Date of Electronic Publication: 2025 Oct 17. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1942 (Electronic) Linking ISSN: 01145916 NLM ISO Abbreviation: Drug Saf Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41105321 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Navigating Non-interventional Post-authorization Studies in East Asia: Regulatory Challenges, Opportunities, and Future Directions. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Peters+J%22">Peters J</searchLink>; Gilead Sciences Inc., Foster City, CA, USA. jami.peters5@gilead.com.<br /><searchLink fieldCode="AU" term="%22Ali+AK%22">Ali AK</searchLink>; BeOne Medicines Ltd., San Carlos, CA, USA.<br /><searchLink fieldCode="AU" term="%22Moitinho+de+Almeida+M%22">Moitinho de Almeida M</searchLink>; GSK, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22Asao+K%22">Asao K</searchLink>; Kappa Medical K.K., Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Hammad+TA%22">Hammad TA</searchLink>; Takeda Development Center Americas, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22He+X%22">He X</searchLink>; IQVIA, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Michel+A%22">Michel A</searchLink>; Bayer Consumer Care AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Rubino+A%22">Rubino A</searchLink>; Gilead Sciences Europe Ltd, Uxbridge, UK.<br /><searchLink fieldCode="AU" term="%22Sawada+S%22">Sawada S</searchLink>; Nippon Boehringer Ingelheim Co., Ltd., Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Sobel+RE%22">Sobel RE</searchLink>; Regeneron Pharmaceuticals, Tarrytown, NY, USA.<br /><searchLink fieldCode="AU" term="%22de+Vogel+S%22">de Vogel S</searchLink>; Astellas Pharma Europe B.V., Leiden, The Netherlands. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229002928%22">Drug safety</searchLink> [Drug Saf] 2026 Mar; Vol. 49 (3), pp. 263-271. <i>Date of Electronic Publication: </i>2025 Oct 17. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>9002928 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-1942 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201145916%22">01145916 </searchLink><i>NLM ISO Abbreviation: </i>Drug Saf <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41105321 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s40264-025-01621-x Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 263 Titles: – TitleFull: Navigating Non-interventional Post-authorization Studies in East Asia: Regulatory Challenges, Opportunities, and Future Directions. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Peters J – PersonEntity: Name: NameFull: Ali AK – PersonEntity: Name: NameFull: Moitinho de Almeida M – PersonEntity: Name: NameFull: Asao K – PersonEntity: Name: NameFull: Hammad TA – PersonEntity: Name: NameFull: He X – PersonEntity: Name: NameFull: Michel A – PersonEntity: Name: NameFull: Rubino A – PersonEntity: Name: NameFull: Sawada S – PersonEntity: Name: NameFull: Sobel RE – PersonEntity: Name: NameFull: de Vogel S IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: 2026 Mar Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1179-1942 Numbering: – Type: volume Value: 49 – Type: issue Value: 3 Titles: – TitleFull: Drug safety Type: main |
| ResultId | 1 |